Academia and industry agreement on a feasibility tool for first‐time‐in‐human clinical trial units

Academia and industry agreement on a feasibility tool for first‐time‐in‐human clinical trial units

Abstract First‐time‐in‐human (FTIH) trials are designed to generate information on the safety, tolerability, as well as the pharmacokinetic and pharmacodynamics profile of new drugs. To ensure the safety of participants, these trials need to be conducted at specifically equipped phase I clinical tri...

Full description

Bibliographic Details
Main Authors: Paloma Moraga, Paula Prieto, Almari Conradie, Majda Benhayoun, Vicki Rousell, Maria Davy, Uwe Fuhr, Rosa Antonijoan Arbos, Francisco Abad‐Santos, Antonio Portolés, Jolanda Van Duinen, Antonio J. Carcas, Alberto M. Borobia, the ERA4TB Consortium
Format: Article
Language:English
Published: Wiley 2023-12-01
Series:Clinical and Translational Science
Online Access:https://doi.org/10.1111/cts.13655

Internet

https://doi.org/10.1111/cts.13655

Similar Items